3D Bioprinted Breast Cancer Models for Enhanced Drug Testing and Metabolic Studies

3D Bioprinted Breast Cancer Models for Enhanced Drug Testing and Metabolic Studies: Despite advancements in modeling the complex tumor microenvironment, conventional breast cancer models often fall short in providing accurate insights into cancer biology and drug efficacy. Accurately modeling this environment could improve the efficacy and safety of cancer treatments by offering more accurate preclinical [...]

October 29th, 2024|

Efficient Microalgae Separation Using Dielectrophoresis in a Microfluidic Flow Cell

Efficient Microalgae Separation Using Dielectrophoresis in a Microfluidic Flow Cell: Microalgae are a valuable source of poly-unsaturated fatty acids, which are applied in various biotechnological fields such as pharmaceuticals and food supplements. Separating microalgae cells based on their lipid content could be relevant for at-line analytical techniques and strain selection. In a study done by [...]

August 21st, 2024|

Advancing Cancer Research with 3D Bioprinting Realistic Models

Advancing Cancer Research with 3D Bioprinting Realistic Models: Cancer progression is influenced by complex interactions between cancer cells and their surrounding stromal environment. Traditional 2D cell cultures and animal models have limitations in capturing this complexity. Therefore, researchers are increasingly adopting 3D in-vitro models that more accurately mimic the tumor microenvironment. A team of researchers [...]

July 19th, 2024|

Bioink for 3D-Bioprinting with Decellularized Bone Particles

Bioink for 3D-Bioprinting with Decellularized Bone Particles: Biofabrication is a technology that uses extrusion printing methods to create three-dimensional (3D) living tissue structures. One of the key challenges in biofabrication is maintaining the shape fidelity of the 3D-printed constructs while allowing cell proliferation. Material characteristics directly affect printability, shape fidelity, and cell behavior post-bioprinting. Gelatin [...]

June 17th, 2024|

Controlled Release of Growth Factors in Bioprinted Respiratory Scaffolds

Controlled Release of Growth Factors in Bioprinted Respiratory Scaffolds: Tissue engineering is a rapidly evolving field that seeks to stimulate and control tissue generation and regeneration by incorporating cells, biocompatible materials, and bioactive molecules. Both the mechanical and chemical environments provide cues and signaling factors that significantly influence cellular development. Among these, growth factors are [...]

May 14th, 2024|

Tissue Engineering with combination of FDM and MEW

Tissue Engineering with combination of FDM and MEW: Patient-specific treatments have become increasingly crucial in modern medicine. As personalized care gains prominence, the demand for innovative technologies to fulfill these requirements has arisen. Enter additive manufacturing (AM)—a promising solution that holds immense potential. Researchers at the University of Otago aimed to combine two additive manufacturing [...]

April 10th, 2024|

Transforming Tendon Reconstruction: The GeSiM BioScaffolder’s Role in Hybrid Scaffold Innovation

Transforming Tendon Reconstruction: The GeSiM BioScaffolder's Role in Hybrid Scaffold Innovation Tendons are connective tissues that attach muscles to bones and enable joint movement. However, tendon injuries are common and often difficult to heal, requiring surgical intervention with autologous materials and long-term rehabilitation. The use of regenerative grafts, which mimic mechanical properties while supporting the [...]

March 1st, 2024|

Revolutionizing Food Safety: Lab-in-a-Package

Revolutionizing Food Safety: Lab-in-a-Package: In a world where food safety is essential, a paper published by researchers at the McMaster University (CA), GeSiM’s customer, introduces a game-changing solution: Lab-in-a-Package. This innovative approach aims to transform the way we detect and prevent foodborne illnesses, offering a hands-free, real-time method within the confines of a closed food [...]

February 6th, 2024|

LifeCare’s Cutting-Edge Approach: GeSiM Machines Enable Series Production of Chip-based Glucose Sensor

LifeCare's Cutting-Edge Approach: GeSiM Machines Enable Series Production of Chip-based Glucose Sensor: LifeCare, a forward-thinking medical sensor company, recently published a groundbreaking move towards automated production through a strategic purchase order from GeSiM mbH. This significant step not only demonstrates LifeCare's commitment to advancing medical sensor technology but also showcases the incredible flexibility and customization [...]

January 11th, 2024|

A GeSiM Bioprinter beyond Gravity

A GeSiM Bioprinter beyond Gravity: A team from Dresden University Hospital has now tested a GeSiM bioprinter in a non-gravitational environment. The device was taken on board of an AIR ZERO G aircraft and put into operation there. During several parabolic flights, it was possible to demonstrate that the device functions perfectly in a micro-G [...]

November 10th, 2023|
Go to Top